General Information


DRAVP ID  DRAVPe02410

Peptide Name   P95

Sequence  KKKKVVAATYVTV

Sequence Length  13

UniProt ID  P26662 

Taxon ID  11116 

Source  Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)

Other Link  10.1177/095632020301400501

Validation   Experimentally Validated



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Genomic RNA

Chromosomal Position  Not Available



Activity Information


Target Organism  HCV

Assay  Fluorescent probe

Activity 

  • [Ref:14694985]HCV:IC50=inhibition of activation of NS3-6K protease(50 nM)(0.1% inhibition at 3 µM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity  No cytotoxicity information found in the reference(s) presented

Binding Target  NS3 protease

Mechanism  HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication



Structure Information


PDB ID  1DXP  1DY8 

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  H42C65N11O10S2

Absent amino acids  DEGHIMQRSTVWY

Common amino acids  ACFKLNP

Mass  966.1784

Pl  8.05837078094482

Basic residues  1

Acidic residues  0

Hydrophobic residues  6

Net charge  0.739300632992282

Boman Index  0.814

Hydrophobicity  0.688888888888888

Aliphatic Index  65.56

Half Life 

  •     Mammalian:1.2 hours
  •     Yeast:1 hours
  •     E.coli:1.1 hours

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3



Literature Information


Literature 1

Title   Peptide inhibitors of hepatitis C virus NS3 protease.

Pubmed ID   14694985

Reference   Antivir Chem Chemother. 2003 Sep;14(5):225-33.

Author   Portal-Nunez S, Gonzalez-Navarro CJ, Garcia-Delgado M, Vizmanos JL, Lasarte JJ, Borras-Cuesta F.

DOI   10.1177/095632020301400501